Path BioAnalytics will employ InSphero 3D cell technology to produce organoids from primary cystic fibrosis patient tissues to aid in development of new treatments.
AstraZeneca Relies on 3D InSight™ Human Islet Microtissues in Pancreatic Beta-cell Study InSphero human islet model helps reveal effects of gene silencing on pancreatic cell
Government research project to predict hepatic clearance of drugs in humans using Akura™ Flow system results in development partnerships with top pharma companies.
Comprehensive, customizable platforms for preclinical drug safety and efficacy testing, coupled with emerging organ-on-a-chip technology, garner investor support
InSphero extends 3D InSight™ Diabetes Discovery Platform to include ALPCO STELLUX® Chemiluminescent ELISA technology for assessment of pancreatic β-cell function.
Global leader in 3D cell culture technology to deliver standardized 3D models in advanced microfluidic format ideal for organ on a chip applications.
Nanosafety experts from more than 30 institutions convene in Swansea, Wales, for PATROLS project kick off meeting.
InSphero demonstrates commitment to customer satisfaction, superior quality, and continuous improvement by adhering to new ISO 9001:2015 standards.
Charles River to license PDX lines to InSphero for development of 3D InSight™ PDX Microtissues, expansion of in vitro oncology services.
InSphero to Present Novel 3D Human Liver Fibrosis Model at Annual Liver Meeting® in Washington, DC New 3D InSight™ Human Liver Fibrosis Model represents a
Ready to unlock the full potential of 3D in vitro? Help us better understand your challenges and interests, and let's get started!
USA and Canada
Phone : +1 908-864-1550
TechPlace, 74 Orion St., Brunswick, ME 04011 USA
Europe and Rest of World
Phone : +41 44 515 04 90
Wagistrasse 27A, 8952, Schlieren, Switzerland